HeMemics Biotechnologies, Inc, a Rockville-based TEDCO portfolio company, received a $2.5 million investment from AMVI Partners
Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases
LEARN MORE